Effects of γ-synuclein on the tumorigenicity and metastasis of colon cancer SW1116 cells in vitro and in vivo

Oncology Reports

Volumn 30, Issue 5, 2013, Pages 2161-2170

  Ye, Qing ^a,b   Huang, Feng ^a,b   Wang, Xiao Ying ^a,b   Xu, Yang Mei ^a,b   Gong, Fu Sheng ^a,b   Huang, Li Jie ^a,b   Yang, Chun Kang ^a,b   Zheng, Qiu Hong ^a,b   Ying, Min Gang ^a,b  

^a FUJIAN PROVINCIAL TUMOR HOSPITAL   (China)

^b Fujian Key Laboratory of Translational Cancer Medicine   (China)

Author keywords

synuclein; Colorectal cancer; In vitro; In vivo; Metastasis; Tumorigenicity

Indexed keywords

GAMMA SYNUCLEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER SIZE; LIVER WEIGHT; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; GAMMA-SYNUCLEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICE; RNA, SMALL INTERFERING;

EID: 84885038888     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2688     Document Type: Article

References (32)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics. CA Cancer J Clin 63: 11-30, 2013.
2. Mayo SC and Pawlik TM: Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol 3: 131-144, 2009.
3. Berri RN and Abdalla EK: Curable metastatic colorectal cancer: recommended paradigms. Curr Oncol Rep 11: 200-208, 2009.
4. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC and Weinberg RA: The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA 103: 18969-18974, 2006.
5. Mani SA, Yang J, Brooks M, et al: Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 104: 10069-10074, 2007.
6. Yang J, Mani SA, Donaher JL, et al: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939, 2004.
7. Surguchov A: Molecular and cellular biology of synucleins. Int Rev Cell Mol Biol 270: 225-317, 2008.
8. Ahmad M, Attoub S, Singh MN, Martin FL and El-Agnaf OM: γ-Synuclein and the progression of cancer. FASEB J 21: 3419-3430, 2007.
9. Ji H, Liu YE, Jia T, et al: Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57: 759-764, 1997.
10. Guo J, Shou C, Meng L, et al: Neuronal protein synuclein γ predicts poor clinical outcome in breast cancer. Int J Cancer 121: 1296-1305, 2007.
11. Hibi T, Mori T, Fukuma M, et al: Synuclein-γ is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer. Clin Cancer Res 15: 2864-2871, 2009.
12. Dokun OY, Florl AR, Seifert HH, Wolff I and Schulz WA: Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer. Int J Cancer 123: 2798-2807, 2008.
13. Liu H, Liu W, Wu Y, et al: Loss of epigenetic control of synuclein-γ gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 65: 7635-7643, 2005.
14. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F and Cordon-Cardo C: Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24: 778-789, 2006.
15. Fung KM, Rorke LB, Giasson B, Lee VM and Trojanowski JQ: Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas. Acta Neuropathol 106: 167-175, 2003.
16. Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ and Godwin AK: Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88: 2154-2163, 2000.
17. Ye Q, Wang TF, Peng YF, et al: Expression of α-, β- and γ-synuclein in colorectal cancer, and potential clinical significance in progression of the disease. Oncol Rep 23: 429-436, 2010.
18. Ye Q, Zheng MH, Cai Q, et al: Aberrant expression and demethylation of γ-synuclein in colorectal cancer, correlated with progression of the disease. Cancer Sci 99: 1924-1932, 2008.
19. Jia T, Liu YE, Liu J and Shi YE: Stimulation of breast cancer invasion and metastasis by synuclein γ. Cancer Res 59: 742-747, 1999.
20. Surgucheva IG, Sivak JM, Fini ME, Palazzo RE and Surguchov AP: Effect of γ-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 410: 167-176, 2003.
21. Gupta A, Inaba S, Wong OK, Fang G and Liu J: Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 22: 7593-7599, 2003.
22. Inaba S, Li C, Shi YE, Song DQ, Jiang JD and Liu J: Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 94: 25-35, 2005.
23. Pan ZZ, Bruening W and Godwin AK: Involvement of RHO GTPases and ERK in synuclein-γ enhanced cancer cell motility. Int J Oncol 29: 1201-1205, 2006.
24. Gennari L, Russo A and Rossetti C: Colorectal cancer: what has changed in diagnosis and treatment over the last 50 years? Tumori 93: 235-241, 2007.
25. Samoha S and Arber N: Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side. Oncology 69: 33-37, 2005.
26. Zhou CQ, Liu S, Xue LY, et al: Down-regulation of γ-synuclein in human esophageal squamous cell carcinoma. World J Gastroenterol 9: 1900-1903, 2003.
27. Pan ZZ, Bruening W, Giasson BI, Lee VM and Godwin AK: γ-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J Biol Chem 277: 35050-35060, 2002.
28. Liu YE, Pu W, Jiang Y, Shi D, Dackour R and Shi YE: Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma. Oncogene 26: 2115-2125, 2007.
29. Jiang Y, Liu YE, Goldberg ID and Shi YE: γ-synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor α signaling and mammary tumorigenesis. Cancer Res 64: 4539-4546, 2004.
30. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006.
31. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
32. Hu H, Sun L, Guo C, et al: Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res 15: 5485-5493, 2009.